SOFIA (Bulgaria), October 24 (SeeNews) – The shareholders of Bulgarian veterinary drugs producer Biovet [BUL:53B] gave the green light on Friday to its management to pledge the company as collateral for loans to be drawn by its parent companies Huvepharma and Huvepharma International.